Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10–24 years from 1990 to 2019: A trend analysis based on the Global Burden of Disease Study 2019. Lancet Child Adolesc Heal [Internet]. 2022 Nov 1 [cited 2023 Apr 2];6(11):763–76. Available from: http://www.thelancet.com/article/S235246422200219X/fulltext

Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet [Internet]. 2012 Dec 15 [cited 2023 Mar 31];380(9859):2197–223. Available from: http://www.thelancet.com/article/S0140673612616894/fulltext

Li Y, You S, Lee K, Yaesoubi R, Hsu K, Gift TL, et al. The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018. J Infect Dis [Internet]. 2023 Apr 18 [cited 2023 Jun 6];227(8). Available from: https://pubmed.ncbi.nlm.nih.gov/36806950/

Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS [Internet]. 2016 Jul 7 [cited 2023 Mar 22];30(12):1973. Available from: /pmc/articles/PMC4949005/

Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med [Internet]. 2015 Dec 3 [cited 2023 Mar 23];373(23):2237–46. https://doi.org/10.1056/NEJMoa1506273

Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med [Internet]. 2012 Aug 2 [cited 2023 Mar 23];367(5):399–410. https://doi.org/10.1056/NEJMoa1108524

Ong JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: A systematic review and meta-analysis. JAMA Netw Open [Internet]. 2019 Dec 13 [cited 2023 Mar 25];2(12). Available from: /pmc/articles/PMC6991203/

Kenyon CR, Osbak K, Tsoumanis A. The global epidemiology of syphilis in the past century – A systematic review based on antenatal syphilis prevalence. PLoS Negl Trop Dis [Internet]. 2016 May 11 [cited 2023 Jun 15];10(5). Available from: /pmc/articles/PMC4864207/

Tripathy DM, Gupta S, Vasudevan B. Resurgence of syphilis, the great imitator. Med J Armed Forces India. 2022;78(2):131–5.

Article  PubMed  PubMed Central  Google Scholar 

Ramchandani MS, Cannon CA, Marra CM. Syphilis: A modern resurgence. Infect Dis Clin North Am. 2023;37(2):195–222.

Article  PubMed  Google Scholar 

Schmidt R, Carson PJ, Jansen RJ. Resurgence of syphilis in the United States: An assessment of contributing factors. Infect Dis (Auckl) [Internet]. 2019 Jan [cited 2023 Jul 4];12:117863371988328. Available from: /pmc/articles/PMC6798162/

Dos Santos MM, Lopes AKB, Roncalli AG, De Lima KC. Trends of syphilis in Brazil: A growth portrait of the treponemic epidemic. PLoS One [Internet]. 2020 Apr 1 [cited 2023 Jul 4];15(4). Available from: /pmc/articles/PMC7145144/

Kojima N, Klausner JD. An update on the global epidemiology of syphilis. Curr Epidemiol reports [Internet]. 2018 Mar [cited 2023 Jun 15];5(1):24. Available from: /pmc/articles/PMC6089383/

WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: Module 1: Clinical [Internet]. [cited 2023 Mar 31]. Available from: https://apps.who.int/iris/handle/10665/255889

Blumenthal J, Haubrich RH. Will risk compensation accompany pre-exposure prophylaxis for HIV? Virtual Mentor. 2014;16(11):909–15.

PubMed  PubMed Central  Google Scholar 

McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet [Internet]. 2016 Jan 2 [cited 2023 Mar 23];387(10013):53–60. Available from: http://www.thelancet.com/article/S0140673615000562/fulltext

Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: A systematic review and meta-analysis. Clin Infect Dis [Internet]. 2018 Aug 16 [cited 2023 Mar 23];67(5):676–86. Available from: https://academic.oup.com/cid/article/67/5/676/4917600

Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Lancet HIV [Internet]. 2019 Jul 1 [cited 2023 Mar 23];6(7):e447–55. Available from: http://www.thelancet.com/article/S2352301819301365/fulltext

Zablotska IB, Vaccher SJ, Bloch M, Carr A, Foster R, Grulich A, et al. High adherence to HIV pre-exposure prophylaxis and no HIV seroconversions despite high levels of risk behaviour and STIs: The Australian demonstration study PrELUDE. AIDS Behav [Internet]. 2019 Jul 15 [cited 2023 Mar 23];23(7):1780–9. Available from: https://link.springer.com/article/https://doi.org/10.1007/s10461-018-2290-3

Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart LE, et al. Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting. AIDS Behav [Internet]. 2019 Feb 15 [cited 2023 Mar 24];23(2):548. Available from: /pmc/articles/PMC6368873/

Disease data from ECDC Surveillance Atlas - Syphilis [Internet]. [cited 2023 Mar 24]. Available from: https://www.ecdc.europa.eu/en/syphilis/surveillance-and-disease-data/disease-data-atlas

STD data and statistics [Internet]. [cited 2023 Mar 24]. Available from: https://www.cdc.gov/std/statistics/default.htm

Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA [Internet]. 2019 Apr 4 [cited 2023 Mar 24];321(14):1380. Available from: /pmc/articles/PMC6459111/

Beymer MR, DeVost MA, Weiss RE, Dierst-Davies R, Shover CL, Landovitz RJ, et al. Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California. Sex Transm Infect [Internet]. 2018 Sep 1 [cited 2023 Mar 23];94(6):457–62. Available from: https://sti.bmj.com/content/94/6/457

Nguyen VK, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS [Internet]. 2018 Feb 20 [cited 2023 Mar 23];32(4):523–30. Available from: https://journals.lww.com/aidsonline/Fulltext/2018/02200/Incidence_of_sexually_transmitted_infections.13.aspx

World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. :201.

Zemouri C, Wi TE, Kiarie J, Seuc A, Mogasale V, Latif A, et al. The performance of the vaginal discharge syndromic management in treating vaginal and cervical infection: A systematic review and meta-analysis. PLoS One [Internet]. 2016 Oct 1 [cited 2023 Mar 31];11(10):e0163365. Available from: https://journals.plos.org/plosone/article?id=https://doi.org/10.1371/journal.pone.0163365

Peeling RW, Mabey D, Herring A, Hook EW. Why do we need quality-assured diagnostic tests for sexually transmitted infections? Nat Rev Microbiol 2006 412 [Internet]. 2006 Dec [cited 2023 Mar 31];4(12):S7–19. Available from: https://www.nature.com/articles/nrmicro1569

Otieno FO, Ndivo R, Oswago S, Ondiek J, Pals S, McLellan-Lemal E, et al. Evaluation of syndromic management of sexually transmitted infections within the Kisumu Incidence Cohort Study. Int J STD AIDS [Internet]. 2014 Oct 13 [cited 2023 Jun 7];25(12):851. Available from: /pmc/articles/PMC4586058/

Pettifor A, Walsh J, Wilkins V, Raghunathan P. How effective is syndromic management of STDs?: A review of current studies. Sex Transm Dis [Internet]. 2000 [cited 2023 Mar 31];27(7):371–85. Available from: https://pubmed.ncbi.nlm.nih.gov/10949428/

Van Gemert C, Hellard M, Bradshaw CS, Fowkes FJI, Agius PA, Stoove M, et al. Syndromic management of sexually transmissible infections in resource-poor settings: A systematic review with meta-analysis of the abnormal vaginal discharge flowchart for Neisseria gonorrhoea and Chlamydia trachomatis. Sex Health [Internet]. 2017 Aug 25 [cited 2023 Mar 31];15(1):1–12. Available from: https://www.publish.csiro.au/sh/SH17070

Repeat syphilis infections in men who have sex with men, 2000–2005, Chicago, IL [Internet]. [cited 2023 Jun 15]. Available from: https://cdc.confex.com/cdc/std2006/techprogram/P10609.HTM

Kenyon C, Osbak KK, Apers L. Repeat syphilis is more likely to be asymptomatic in HIV-infected individuals: A retrospective cohort analysis with important implications for screening. Open Forum Infect Dis [Internet]. 2018 Jun 1 [cited 2023 Jun 15];5(6). Available from: /pmc/articles/PMC6016412/

WHO PrEP implementation tool [Internet]. [cited 2023 Jun 7]. Available from: https://www.who.int/tools/prep-implementation-tool

•• Tang EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, Bacon O, Chege W, et al. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis. AIDS [Internet]. 2020 Jul 1 [cited 2023 Jun 7];34(8):1181–6. Available from: https://journals.lww.com/aidsonline/Fulltext/2020/07010/Quarterly_screening_optimizes_detection_of.9.aspx

•• Van Wifferen F, Hoornenborg E, Schim Van Der Loeff MF, Heijne J, Van Hoek AJ. Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: A modelling study. Sex Transm Infect [Internet]. 2021 Dec 1 [cited 2023 Jun 7];97(8):607–12. Available from: https://sti.bmj.com/content/97/8/607

Jongen VW, Zimmermann HML, Goedhart M, Bogaards JA, Davidovich U, Coyer L, et al. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study. Sex Transm Infect [Internet]. 2022 May 18 [cited 2023 Apr 3];0:1–7. Available from: https://sti.bmj.com/content/early/2022/05/17/sextrans-2022-055439

Jansen K, Steffen G, Potthoff A, Schuppe AK, Beer D, Jessen H, et al. STI in times of PrEP: High prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. BMC Infect Dis [Internet]. 2020 Feb 7 [cited 2023 Apr 6];20(1). Available from: /pmc/articles/PMC7007644/

•• Radovanovic M, Kekic D, Jovicevic M, Kabic J, Gajic I, Opavski N, et al. Current susceptibility surveillance and distribution of antimicrobial resistance in N. gonorrheae within WHO regions. Pathogens [Internet]. 2022 Nov 1 [cited 2023 Apr 7];11(11). Available from: /pmc/articles/PMC9697523/

Patton ME, Kidd S, Llata E, Stenger M, Braxton J, Asbel L, et al. Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men—STD Surveillance Network, United States, 2010–2012. Clin Infect Dis [Internet]. 2014 Jun 1 [cited 2023 Jun 7];58(11):1564–70. Available from: https://dx.doi.org/https://doi.org/10.1093/cid/ciu184

Quilter laura S, Obondi eve, Kunzweiler colin, Okall D, Bailey robert, Djomand gaston, et al. Prevalence and correlates of and a risk score to identify asymptomatic anorectal gonorrhoea and chlamydia infection among men who have sex with men in Kisumu, Kenya. Sex Transm Infect [Internet]. 2019 [cited 2023 Jul 3];95:201–11. Available from: http://sti.bmj.com/

Cohen MS. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet (London, England) [Internet]. 1998 [cited 2023 Apr 6];351 Suppl 3(SUPPL.3):5–7. Available from: https://pubmed.ncbi.nlm.nih.gov/9652712/

Koedijk FDH, van Bergen JEAM, Dukers-Muijrers NHTM, van Leeuwen AP, Hoebe CJPA, van der Sande MAB. The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006–2010. Int J STD AIDS [Internet]. 2012 Sep 1 [cited 2023 Apr 6];23(9):626–31. Available from: https://pubmed.ncbi.nlm.nih.gov/23033514/

Papp JR, Schachter J, Gaydos CA, Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014. MMWR Recomm Rep [Internet]. 2014 Mar 3 [cited 2023 Jul 3];63(0):1. Available from: /pmc/articles/PMC4047970/

Marfatia Y, Pandya I, Mehta K. Condoms: Past, present, and future. Indian J Sex Transm Dis AIDS [Internet]. 2015 Jul 1 [cited 2023 Jun 7];36(2):133. Available from: /pmc/articles/PMC4660551/

Schwartz RM, Bruno DM, Augenbraun MA, Hogben M, Joseph MA, Liddon N, et al. Perceived financial need and sexual risk behavior among urban, minority patients following sexually transmitted infection diagnosis. Sex Transm Dis [Internet]. 2011 Mar [cited 2023 Apr 2];38(3):230–4. Available from: https://journals.lww.com/stdjournal/Fulltext/2011/03000/Perceived_Financial_Need_and_Sexual_Risk_Behavior.16.aspx

Stewart J, Bukusi E, Celum C, Delany-Moretlwe S, Baeten JM. Sexually transmitted infections among African women: An underrecognized epidemic and an opportunity for combination STI/HIV prevention. AIDS [Internet]. 2020 Apr 4 [cited 2023 Apr 2];34(5):651. Available from: /pmc/articles/PMC7290066/

Grant JS, Stafylis C, Celum C, Grennan T, Haire B, Kaldor J, et al. Doxycycline prophylaxis for bacterial sexually transmitted infections. Clin Infect Dis An Off Publ Infect Dis Soc Am [Internet]. 2020 Mar 3 [cited 2023 Mar 24];70(6):1247. Available from: /pmc/articles/PMC7319058/

Stewart J, Bukusi E, Sesay FA, Oware K, Donnell D, Soge OO, et al. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: Study protocol for an open-label randomized trial. Trials [Internet]. 2022 Dec 1 [cited 2023 Apr 3];23(1). Available from: https://pubmed.ncbi.nlm.nih.gov/35710444/

Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis [Internet]. 2018 Mar 1 [cited 2023 Apr 2];18(3):308–17. Available from: http://www.thelancet.com/article/S1473309917307259/fulltext

Luetkemeyer A, Dombrowski J, Cohen S, Donnell D, Grabow C, Brown C, et al. Doxycycline post-exposure prophylaxis for prevention of STIs among MSM and TGW who are living with HIV or on PrEP co-chairs choice. [cited 2023 Apr 2]; Available from: https://www.cdc.gov/std/statistics/2020

•• Mucosal pharmacology of doxycycline for bacterial STI prevention in men and women [Internet]. [cited 2023 Apr 2]. Available from: https://www.croiconference.org/abstract/mucosal-pharmacology-of-doxycycline-for-bacterial-sti-prevention-in-men-and-women/

•• Doxycycline postexposure prophylaxis for prevention of STIs among cisgender women [Internet]. [cited 2023 Apr 2]. Available from: https://www.croiconference.org/abstract/doxycycline-postexposure-prophylaxis-for-prevention-of-stis-among-cisgender-women/

Full schedule [Internet]. [cited 2023 Aug 23]. Available from: https://stihiv2023.eventscribe.net/agenda.asp?pfp=days&day=7/25/2023&theday=Tuesday&h=Tuesday July 25&BCFO=P%7CG

Update S. Health update doxycycline post-exposure prophylaxis reduces incidence of sexually transmitted infections. 2022;

Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel. JAMA [Internet]. 2023 Jan 3 [cited 2023 Apr 3];329(1):63–84. Available from: https://jamanetwork.com/journals/jama/fullarticle/2799240

Haas K, Notay M, Rodriguez W, Rolston M, Clark A, Burney W, et al. 383 Doxycycline effects on the gut and skin microbiomes and lipidome in acne. J Invest Dermatol [Internet]. 2018 May 1 [cited 2023 Jun 19];138(5):S65. Available from: http://www.jidonline.org/article/S0022202X18306158/fulltext

•• Bruxvoort KJ, Lewnard JA, Chen LH, Tseng HF, Chang J, Veltman J, et al. Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: A matched cohort study in Southern California. Clin Infect Dis [Internet]. 2023 Feb 8 [cited 2023 Apr 2];76(3):e1341–9. Available from: https://academic.oup.com/cid/article/76/3/e1341/6596517

•• Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, et al. ANRS DOXYVAC: Final analysis may modify interim results of this trial assessing the effectiveness of meningococcal B vaccination in preventing gonococcal infections | EATG. https://www.eatg.org/ [Internet]. 2023 Apr 6 [cited 2023 May 24];388(14):1296–306. Available from: https://www.eatg.org/hiv-news/anrs-doxyvac-final-analysis-may-modify-interim-results-of-this-trial-assessing-the-effectiveness-of-meningococcal-b-vaccination-in-preventing-gonococcal-infections/

Whittles LK, Didelot X, White PJ. Public health impact and cost-effectiveness of gonorrhoea vaccination: An integrated transmission-dynamic health-economic modelling analysis. Lancet Infect Dis [Internet]. 2022 Jul 1 [cited 2023 Jul 7];22(7):1030–41. Available from: http://www.thelancet.com/article/S1473309921007441/fulltext

Ona S, Molina RL, Diouf K. Mycoplasma genitalium: An overlooked sexually transmitted pathogen in women? Infect Dis Obstet Gynecol. 2016;2016.

Peel J, Aung E, Bond S, Bradshaw C. Recent advances in understanding and combatting Mycoplasma genitalium. Fac Rev. 2020;30:9.

Google Scholar 

•• Sokoll PR, Migliavaca CB, Siebert U, Schmid D, Arvandi M. Prevalence of Mycoplasma genitalium infection among HIV PrEP users: A systematic review and meta-analysis. Sex Transm Infect [Internet]. 2023 Feb 20 [cited 2023 Mar 31];0:1–9. Available from: https://sti.bmj.com/content/early/2023/02/19/sextrans-2022-055687

Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A, Reiner RC, et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis [Internet]. 2017 Sep 1 [cited 2023 Jun 20];17(9):909. Available from: /pmc/articles/PMC5589208/

Braam JF, Bruisten SM, Hoogeland M, de Vries HJC, Schim van der Loeff MF, van Dam AP. Shigella is common in symptomatic and asymptomatic men who have sex with men visiting a sexual health clinic in Amsterdam. Sex Transm Infect [Internet]. 2022 Dec 1 [cited 2023 Jun 20];98(8):564–9. Available from: https://sti.bmj.com/content/98/8/564

Newman KL, Newman GS, Cybulski RJ, Fang FC. Gastroenteritis in men who have sex with men in Seattle, Washington, 2017–2018. Clin Infect Dis [Internet]. 2020 Jul 1 [cited 2023 Jul 5];71(1):109–15. Available from: https://pubmed.ncbi.nlm.nih.gov/31621824/

Baker KS, Dallman TJ, Ashton PM, Day M, Hughes G, Crook PD, et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: A cross-sectional study. Lancet Infect Dis [Internet]. 2015 [cited 2023 Jun 20];15:913–21.https://doi.org/10.1016/S1473-3099(15)00002-X

Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A review of the literature. Infect Dis Obstet Gynecol [Internet]. 2016 [cited 2023 Apr 7];2016. Available from: https://pubmed.ncbi.nlm.nih.gov/27366021/

Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: An ongoing challenge. J Mol Diagnostics [Internet]. 2006 Feb 1 [cited 2023 Jul 3];8(1):3–15. Available from: http://www.jmdjournal.org/article/S1525157810602875/fulltext

World Health Organization. Reproductive health and research. WHO guidelines for the treatment of Neisseria gonorrhoeae. :55.

Murtagh MM. The point-of-care diagnostic landscape for sexually transmitted infections (STIs).

Sánchez-Busó L, Cole MJ, Spiteri G, Day M, Jacobsson S, Golparian D, et al. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: A genomic surveillance study. The Lancet Microbe [Internet]. 2022 Jun 1 [cited 2023 Apr 7];3(6):e452–63. Available from: https://pubmed.ncbi.nlm.nih.gov/35659907/

Jacobsson S, Golparian D, Scangarella-Oman N, Unemo M. In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae. J Antimicrob Chemother [Internet]. 2018 Aug 1 [cited 2023 Apr 7];73(8):2072–7. Available from: https://pubmed.ncbi.nlm.nih.gov/29796611/

Scangarella-Oman NE, Hossain M, Dixon PB, Ingraham K, Min S, Tiffany CA, et al. Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae. Antimicrob Agents Chemother [Internet]. 2018 Dec 1 [cited 2023 Apr 7];62(12). Available from: https://pubmed.ncbi.nlm.nih.gov/30249694/

Wanninger S, Donati M, Di Francesco A, Hässig M, Hoffmann K, Seth-Smith HMB, et al. Selective pressure promotes tetracycline resistance of Chlamydia suis in fattening pigs. PLoS One [Internet]. 2016 Nov 1 [cited 2023 May 24];11(11). Available from: https://pubmed.ncbi.nlm.nih.gov/27893834/

Sandoz KM, Rockey DD. Antibiotic resistance in Chlamydiae. Future Microbiol [Internet]. 2010 Sep [cited 2023 May 24];5(9):1427. Available from: /pmc/articles/PMC3075073/

Stamm L V. Syphilis: Antibiotic treatment and resistance. Epidemiol Infect [Internet]. 2015 Mar 15 [cited 2023 May 24];143(8):1567–74. Available from: https://pubmed.ncbi.nlm.nih.gov/25358292/

Pintye J, Odoyo J, Nyerere B, Achieng P, Araka E, Omondi C, et al. Nurse-facilitated preexposure prophylaxis delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya. AIDS [Internet]. 2023 Mar 3 [cited 2023 Mar 29];37(4):617. Available from: /pmc/articles/PMC9974532/

Ortblad KF, Mogere P, Roche S, Kamolloh K, Odoyo J, Irungu E, et al. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: Results from a collaborative stakeholder consultation. BMC Health Serv Res [Internet]. 2020 Dec 1 [cited 2023 Mar 29];20(1):1–9. Available from: https://bmchealthservres.biomedcentral.com/articles/https://doi.org/10.1186/s12913-020-05898-9

Barnabas R V., Szpiro AA, van Rooyen H, Asiimwe S, Pillay D, Ware NC, et al. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): A randomised trial. Lancet Glob Heal [Internet]. 2020 Oct 1 [cited 2023 Jul 4];8(10):e1305–15. Available from: http://www.thelancet.com/article/S2214109X20303132/fulltext

Stewart J, Stadeli KM, Green ML, Etter-Carlson L, Dahl E, Davidson GH, et al. A co-located continuity clinic model to address healthcare needs of women living unhoused with opioid use disorder, who engage in transactional sex in north Seattle. Sex Transm Dis [Internet]. 2020 Jan 1 [cited 2023 Jul 4];47(1):e5. Available from: /pmc/articles/PMC6923540/

Grammatico MA, Moll AP, Choi K, Springer SA, Shenoi S V. Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South Africa. J Int AIDS Soc [Internet]. 2021 Nov 1 [cited 2023 Jul 3];24(11). Available from: https://pubmed.ncbi.nlm.nih.gov/34826363/

Cao B, Bao H, Oppong E, Feng S, Smith KM, Tucker JD, et al. Digital health for sexually transmitted infection and HIV services: A global scoping review. Curr Opin Infect Dis [Internet]. 2020 Feb 1 [cited 2023 Jul 4];33(1):44–50. Available from: https://pubmed.ncbi.nlm.nih.gov/31789695/

Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, et al. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Brazilian J Infect Dis [Internet]. 2020 Jul 1 [cited 2021 May 7];24(4):360–4. Available from: /pmc/articles/PMC7261432/

Rousseau E, Julies RF, Madubela N, Kassim S. Novel platforms for biomedical HIV prevention delivery to key populations - Community mobile clinics, peer-supported, pharmacy-led PrEP delivery, and the use of telemedicine. Curr HIV/AIDS Rep [Internet]. 2021 Dec 1 [cited 2023 Apr 6];18(6):500–7. Available from: https://pubmed.ncbi.nlm.nih.gov/34708316/

Young Holt B, Turpin JA, Romano J. Multipurpose prevention technologies: Opportunities and challenges to ensure advancement of the most promising MPTs. Front Reprod Heal. 2021;6:3.

Google Scholar 

Sexually transmitted infections (STIs): Annual data tables - GOV.UK [Internet]. [cited 2023 Jul 4]. Available from: https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables

•• McCuistian C, Peteet B, Burlew K, Jacquez F. Sexual health interventions for racial/ethnic minorities using community-based participatory research: A systematic review. Health Educ Behav [Internet]. 2023 Feb 1 [cited 2023 Apr 6];50(1):107. Available from: /pmc/articles/PMC9004606/

Woode Owusu M, Estupiñán Fdez. De Mesa M, Mohammed H, Gerressu M, Hughes G, Mercer CH. Race to address sexual health inequalities among people of Black Caribbean heritage: Could co-production lead to more culturally appropriate guidance and practice? Sex Transm Infect [Internet]. 2023 May 3 [cited 2023 Jul 4];0(0). Available from: https://sti.bmj.com/content/early/2023/05/02/sextrans-2023-055798

Tucker JD, Tang W, Li H, Liu C, Fu R, Tang S, et al. Crowdsourcing designathon: A new model for multisectoral collaboration. BMJ Innov [Internet]. 2018 Apr 1 [cited 2023 Mar 29];4(2):46–50. Available from: https://innovations.bmj.com/content/4/2/46

Cornelisse VJ, Ong JJ, Ryder N, Ooi C, Wong A, Kenchington P, et al. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand – The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Sex Health [Internet]. 2023 Mar 17 [cited 2023 Apr 3]; Available from: https://www.publish.csiro.au/sh/SH23011

Kohli M, Medland N, Fifer H, Saunders J. BASHH updated position statement on doxycycline as prophylaxis for sexually transmitted infections. Sex Transm Infect [Internet]. 2022 May 1 [cited 2023 Apr 3];98(3):235–6. Available from: https://sti.bmj.com/content/98/3/235